Long-term Safety Study of Alogliptin Used in Combination With Thiazolidine in Participants With Type 2 Diabetes in Japan
Status:
Completed
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to evaluate the long-term safety and efficacy of alogliptin and
Thiazolidine administered once daily (QD) for 40 consecutive weeks in participants who
completed a phase 2/3 Thiazolidine add on study.